Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-006377

Dake Benjamin T sold 10,283 shares at $18.17 ($186,829)

  • Dake Benjamin T acquired 10,283 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-06 Exercise or conversion : show line 1 in the form +2,412 $1.74 $4,197 2,412 D
2023-04-06 Exercise or conversion : show line 2 in the form +7,871 $2.14 $16,844 10,283 D
2023-04-06 Sale : show line 3 in the form −10,283 $18.17 $186,829 0 D
Open-market sales · 10,283 sh · avg $18.17 · $186,829

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-04-06 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −905 $1.74 2030-09-03 905 8,150 D
2023-04-06 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,507 $1.74 2030-09-03 1,507 24,109 D
2023-04-06 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,019 $2.14 2031-04-01 1,019 24,441 D
2023-04-06 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −6,852 $2.14 2031-04-01 6,852 178,167 D
Loading xslF345X04/form4-04072023_060403.xml…